Cited by 372Prion Diseases and Protein MisfoldingAlzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 173 of the 174 references it cites were found in a registry or an index.

Neurodegenerative Diseases: Expanding the Prion Concept

Open access

Walker, Lary C., Jucker, Mathias·2015·Annual Review of Neuroscience

DOI 10.1146/annurev-neuro-071714-033828PMC PMC4803040

Open this paper in CoChat — free account

Abstract

The prion paradigm has emerged as a unifying molecular principle for the pathogenesis of many age-related neurodegenerative diseases. This paradigm holds that a fundamental cause of specific disorders is the misfolding and seeded aggregation of certain proteins. The concept arose from the discovery that devastating brain diseases called spongiform encephalopathies are transmissible to new hosts by agents consisting solely of a misfolded protein, now known as the prion protein. Accordingly, “prion” was defined as a “proteinaceous infectious particle.” As the concept has expanded to include other diseases, many of which are not infectious by any conventional definition, the designation of prions as infectious agents has become problematic. We propose to define prions as “proteinaceous nucleating particles” to highlight the molecular action of the agents, lessen unwarranted apprehension about the transmissibility of noninfectious proteopathies, and promote the wider acceptance of this revolutionary paradigm by the biomedical community.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1146/annurev-neuro-071714-033828

Cites

173 of 173 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
DNA methylation age of human tissues and cell types
Horvath, S. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r115 · Cited by 7,075
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,497
Prions
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Novel Proteinaceous Infectious Particles Cause Scrapie
Prusiner, S. B. (1982) · Science · doi:10.1126/science.6801762 · Cited by 5,221
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495

Show all 174 references

Research works printed but not linked: 3

Baker HF, 1993, Int. J. Exp. Pathol., 74, 441
DeArmond SJ, 1995, Am. J. Pathol., 146, 785
Liberski PP, 2012, Folia Neuropathol., 50, 85

Sorted by citations

Items 201–300 of 372

Structure Preserving Polytopal Discontinuous Galerkin Methods for the Numerical Modeling of Neurodegenerative Diseases
Corti, M., Bonizzoni, F., & Antonietti, P. F. (2024) · Journal of Scientific Computing · doi:10.1007/s10915-024-02581-7 · Cited by 14
From Posttranslational Modifications to Disease Phenotype: A Substrate Selection Hypothesis in Neurodegenerative Diseases
Baskakov, I. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020901 · Cited by 14
Distribution and orientation of nerve fibers and myelin assembly in a brain section retrieved by small-angle neutron scattering
Maiti, S., Frielinghaus, H., Gräßel, D., Dulle, M., Axer, M., & Förster, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-92995-2 · Cited by 13
Increased Gal-3 Mediates Microglia Activation and Neuroinflammation via the TREM2 Signaling Pathway in Prion Infection
Fan, Q., Wu, Y.-Z., Jia, X.-X., Ruhan, A., Liu, C.-M., Zhang, W., Chao, Z.-Y., Zhou, D. H., Wang, Y., Chen, J., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00344 · Cited by 12
Porphyromonas gingivalis Impairs Microglial Aβ Clearance in a Mouse Model
Xie, M., Huang, X., Tang, Q., Yu, S., Zhang, K., Lu, X., Zhang, Y., Wang, J., Zhang, L., & Chen, L. (2025) · Journal of Dental Research · doi:10.1177/00220345241294009 · Cited by 12
Neurodegeneration as Ecosystem Failure: A New Paradigm for Prevention and Treatment
Velikic, G. S., Šupić, G., Marić, D., Puletić, M., Kos, M. O., Vojvodić, D., & Maric, D. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211207 · Cited by 12
Role of viruses, prions and miRNA in neurodegenerative disorders and dementia
Sohrab, S. S., Suhail, M., Ali, A., Kamal, M. A., Husen, A., Ahmad, F., Azhar, E. I., & Greig, N. H. (2018) · VirusDisease · doi:10.1007/s13337-018-0492-y · Cited by 12
Mapping the Fibril Core of the Prion Subdomain of the Mammalian CPEB3 that is Involved in Long Term Memory Retention
Reselammal, D. S., Pinhero, F., Sharma, R. N., Hassan, M. S. O., Srinivasula, S. M., & Vijayan, V. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167084 · Cited by 12
The Influence of Nutrition in Alzheimer's Disease: Neuroinflammation and the Microbiome vs. Transmissible Prion
Bello-Corral, L., Sánchez-Valdeón, L., Verdejo, I. C., Seco‐Calvo, J., Fernández-Fernández, J. A., & Fernández, N. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.677777 · Cited by 12
Therapeutic Potential of Capsaicin in Various Neurodegenerative Diseases with Special Focus on Nrf2 Signaling
Varshney, V., Kumar, A., Parashar, V., Kumar, A., Goyal, A., & Garabadu, D. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010277933231122111244 · Cited by 12
Mechanistic approaches to understand the prion-like propagation of aggregates of the human tau protein
Kumar, H., & Udgaonkar, J. B. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.04.004 · Cited by 12
The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates
Scialò, C., & Legname, G. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.008 · Cited by 12
The gut-brain axis in the pathogenesis of Parkinson’s disease
Meng, L., Yuan, X., Cao, X., & Zhang, Z. (2019) · Brain Science Advances · doi:10.1177/2096595820902566 · Cited by 12
NUEVAS FUENTES DE ANTIOXIDANTES NATURALES: CARACTERIZACIÓN DE COMPUESTOS BIOACTIVOS EN CINCO FRUTOS NATIVOS DE CHILE
Román, M. R., Vásquez, F. N., Villagra, M. F., Zapata, P., Flores, B., & Belchi, M. L. (2020) · Perfiles · doi:10.47187/perf.v2i22.54 · Cited by 12
Dynamics impose limits to detectability of network structure
Asllani, M., da Cunha, B. R., Estrada, E., & Gleeson, J. P. (2020) · New Journal of Physics · doi:10.1088/1367-2630/ab8ef9 · Cited by 11
Impact of α-Synuclein Fibrillar Strains and β-Amyloid Assemblies on Mouse Cortical Neurons Endo-Lysosomal Logistics
Chou, Q.-L., Alik, A., Marquier, F., Melki, R., Treussart, F., & Simonneau, M. (2022) · eNeuro · doi:10.1523/eneuro.0227-21.2022 · Cited by 12
Proteolytic therapeutic modalities for amyloidoses: Insights into immunotherapy, PROTAC, and photo-oxygenation
Kuriyama, M., Wang, C. F., Nagase, T., Sohma, Y., Kanai, M., Hori, Y., & Tomita, T. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00548 · Cited by 11
Anisotropic diffusion and traveling waves of toxic proteins in neurodegenerative diseases
Kevrekidis, P. G., Thompson, T., & Goriely, A. (2020) · Physics Letters A · doi:10.1016/j.physleta.2020.126935 · Cited by 11
A conformation-specific antibody against oligomeric β-amyloid restores neuronal integrity in a mouse model of Alzheimer's disease
He, P., Schulz, P., & Sierks, M. R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015327 · Cited by 11
Strains of Pathological Protein Aggregates in Neurodegenerative Diseases
Wang, X., Noroozian, Z., Lynch, M., Armstrong, N., Schneider, R., Liu, M., Ghodrati, F., Zhang, A. B., Yang, Y. J., Hall, A. C., et al. (2017) · Discoveries · doi:10.15190/d.2017.8 · Cited by 11
Discriminating Strains of Self-Propagating Protein Aggregates Using a Conformational Stability Assay
Lau, H. H. C., Lau, A., & Watts, J. C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7811-3_22 · Cited by 11
Nutrients in Alzheimer’s Disease: The Interaction of Diet, Drugs and Disease
Liyanage, S. I., Vilekar, P., & Weaver, D. F. (2019) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2018.353 · Cited by 11
Contributions of Molecular and Optical Techniques to the Clinical Diagnosis of Alzheimer’s Disease
Bistaffa, E., Tagliavini, F., Matteini, P., & Moda, F. (2020) · Brain Sciences · doi:10.3390/brainsci10110815 · Cited by 11
A Next-Generation Sequencing Study in a Cohort of Sicilian Patients with Parkinson’s Disease
Salemi, M., Lanza, G., Salluzzo, M. G., Schillaci, F. A., Blasi, F. D. D., Cordella, A., Caniglia, S., Lanuzza, B., Morreale, M., Marano, P., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11123118 · Cited by 10
A review of brain injury at multiple time scales and its clinicopathological correlation through in silico modeling
Awasthi, A., Bhaskar, S., Panda, S., & Roy, S. (2024) · Brain Multiphysics · doi:10.1016/j.brain.2024.100090 · Cited by 10
Effects of Heparan Sulfate Trisaccharide Containing Oleanolic Acid in Attenuating Hyperphosphorylated Tau-Induced Cell Dysfunction Associated with Alzheimer’s Disease
Zhu, S., Song, Z., Tapayan, A. S., Singh, K., Wang, K., Hagar, H. C., Zhang, J., Kim, H., Thepsuwan, P., Kuo, M., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02563 · Cited by 10
A network aggregation model for amyloid-$$\beta $$ dynamics and treatment of Alzheimer’s diseases at the brain scale
Brennan, G. S., & Goriely, A. (2025) · Journal of Mathematical Biology · doi:10.1007/s00285-024-02179-5 · Cited by 10
Rapid Conversion of Amyloid-Beta 1-40 Oligomers to Mature Fibrils through a Self-Catalytic Bimolecular Process
Morel, B., Carrasco, M. P., Jurado, S., & Conejero‐Lara, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126370 · Cited by 9
Botulinum neurotoxin A modulates the axonal release of pathological tau in hippocampal neurons
Panzi, C., Surana, S., La‐Rocque, S. D., Moretto, E., Lazo, O. M., & Schiavo, G. (2023) · Toxicon · doi:10.1016/j.toxicon.2023.107110 · Cited by 9
Zooming into Disease at the Nanoscale: High-Speed Atomic Force Microscopy in Biomedical Discovery
Lim, K., & Wong, R. W.-C. (2026) · ACS Nano · doi:10.1021/acsnano.5c20737 · Cited by 8
Unwanted Exacerbation of the Immune Response in Neurodegenerative Disease: A Time to Review the Impact
Leite, A. D. O. F., Bento‐Torres, J., dos Reis, R. R., Sobral, L. L., de Souza, A. C. P., Trévia, N., de Oliveira, R. B., Lins, N. A. D. A., Diniz, D. G., Diniz, J. A. P., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.749595 · Cited by 8
Modelling cerebrovascular pathology and the spread of amyloid beta in Alzheimer’s disease
Ahern, A., Thompson, T., Oliveri, H., Lorthois, S., & Goriely, A. (2025) · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rspa.2024.0548 · Cited by 8
Further insight into the role of metals in amyloid formation by IAPP1-37 and ProIAPP1-48
Mold, M. J., Bunrat, C., Goswami, P., Roberts, A. N., Roberts, C. F., Taylor, N., Taylor, H. K., Wu, L., Fraser, P. E., & Exley, C. (2015) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-4-4 · Cited by 8
What Makes a Prion
MacLea, K. S. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.08.012 · Cited by 8
How Big Is the Yeast Prion Universe?
Zhouravleva, G. A., Bondarev, S. A., & Trubitsina, N. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411651 · Cited by 9
Uncertainty quantification for Fisher-Kolmogorov equation on graphs with application to patient-specific Alzheimer’s disease
Corti, M., Bonizzoni, F., Antonietti, P. F., & Quarteroni, A. M. (2023) · ESAIM Mathematical Modelling and Numerical Analysis · doi:10.1051/m2an/2023095 · Cited by 8
Global Brain Involvement in Posterior Cortical Atrophy: Multimodal MR Imaging Investigation
Glick-Shames, H., Keadan, T., Backner, Y., Bick, A. S., & Levin, N. (2020) · Brain Topography · doi:10.1007/s10548-020-00788-z · Cited by 8
Solvent Composition Effects on the Structural Properties of the Aβ42 Monomer from the 3D-RISM-KH Molecular Theory of Solvation
Blinov, N., Wishart, D. S., & Kovalenko, A. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b00480 · Cited by 7
Path analysis of biomarkers for cognitive decline in early Parkinson’s disease
Gramotnev, D. K., Gramotnev, G., Gramotnev, A., & Summers, M. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268379 · Cited by 6
Gerstmann–Sträussler–Scheinker Disease with F198S Mutation Induces Independent Tau and Prion Protein Pathologies in Bank Voles
Bruno, R., Pirisinu, L., Riccardi, G., D’Agostino, C., Cecco, E. D., Legname, G., Cardone, F., Gambetti, P. L., Nonno, R., Agrimi, U., et al. (2022) · Biomolecules · doi:10.3390/biom12101537 · Cited by 6
Inflammation-Mediated Responses in the Development of Neurodegenerative Diseases
Nainu, F., Mamada, S. S., Harapan, H., & Emran, T. B. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_3 · Cited by 6
Potential Hazards and Biosecurity Aspects Associated on Food Safety
Maldonado-Simán, E. D. J., Ariceaga, C. C. G., Lara, R. R., & Fallas-López, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811445-2.00002-7 · Cited by 6
Decontamination of prions
McDonnell, G., & Comoy, E. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102565-9.00018-2 · Cited by 6
Loss of Residues 119–136, Including the First β-strand of Human Prion Protein, Generates an Aggregation-competent Partially “Open” Form
Hosszu, L. L. P., Sangar, D., Batchelor, M., Risse, E., Hounslow, A. M., Collinge, J., Waltho, J. P., & Bieschke, J. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168158 · Cited by 5
The Aggravating Role of Failing Neuropeptide Networks in the Development of Sporadic Alzheimer’s Disease
Jászberényi, M., Thurzó, B., Jayakumar, A. R., & Schally, A. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313086 · Cited by 5
Prion Diseases
Mercer, R. C. C., McDonald, A. J., Bove‐Fenderson, E., Fang, C., Wu, B., & Harris, D. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00002-x · Cited by 5
Overexpression of mouse prion protein in transgenic mice causes a non-transmissible spongiform encephalopathy
Jackson, G. S., Linehan, J. M., Brandner, S., Asante, E. A., Wadsworth, J. D. F., & Collinge, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-21608-3 · Cited by 5
Prioritizing genes associated with brain disorders by leveraging enhancer-promoter interactions in diverse neural cells and tissues
Zhao, X., Song, L., Yang, A., Zhang, J., Zhang, J., Yang, Y., & Zhao, X. (2023) · Genome Medicine · doi:10.1186/s13073-023-01210-6 · Cited by 5
Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
Donnelly, K. M., & Pearce, M. M. P. (2018) · Journal of Visualized Experiments · doi:10.3791/56906 · Cited by 5
Expanding the prion disease repertoire
Supattapone, S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515143112 · Cited by 4
Dietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies
Kumari, A., & Zeng, X.-A. (2026) · Nutrients · doi:10.3390/nu18060907 · Cited by 4
Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds
Pérez-Rando, M., Dujardin, S., Bennett, R. E., Commins, C., Nibhanupudy, T. J., & Hyman, B. T. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01049-7 · Cited by 4
One or more β-amyloid(s)? New insights into the prion-like nature of Alzheimer's disease
Catania, M., & Fede, G. D. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.07.003 · Cited by 4
Passaging Human Tauopathy Patient Samples in Cells Generates Heterogeneous Fibrils with a Subpopulation Adopting Disease FoldsPreprint
Zeng, Z., Tsay, K., Vijayan, V., Frost, M. P., Prakash, S., Quddus, A., Albert, A., Vigers, M. P., Srivastava, M., Woerman, A. L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.19.549721 · Cited by 4
Elucidation of Molecular Mechanisms of Lipid-Altered Cytotoxicity of TDP-43 Fibrils
Purvinsh, Y., Matveyenka, M., & Kurouski, D. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00934 · Cited by 3
A Decentralized Approach to the Formulation of Hypotheses: A Hierarchical Structural Model for a Prion Self-Assembled System
Wang, M., Zhang, F., Song, C., Shi, P., & Zhu, J. S. (2016) · Scientific Reports · doi:10.1038/srep30633 · Cited by 3
Modeling Necroptotic and Pyroptotic Signaling in Saccharomyces cerevisiae
Barbero-Úriz, Ó., Valenti, M., Molina, M., Fernández‐Acero, T., & Cid, V. J. (2025) · Biomolecules · doi:10.3390/biom15040530 · Cited by 4
Gene Targeted Transgenic Mouse Models in Prion Research
Diack, A. B., Alibhai, J. D., & Manson, J. C. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.06.008 · Cited by 3
Feasibility studies of radioiodinated pyridyl benzofuran derivatives as potential SPECT imaging agents for prion deposits in the brain
Fuchigami, T., Kawasaki, M., Watanabe, H., Nakagaki, T., Nishi, K., Sano, K., Atarashi, R., Nakaie, M., Yoshida, S., Ono, M., et al. (2020) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2020.09.003 · Cited by 3
PrPSc Inhibition and Cellular Protection of DBL on a Prion-Infected Cultured Cell via Multiple Pathways
Yang, W., Chen, C., Chen, J., Xia, Y., Hu, C., Wang, L., Wu, Y.-Z., Shi, Q., Chen, Z., & Dong, X. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02729-2 · Cited by 3
Structures of tau and α-synuclein filaments from brains of patients with neurodegenerative diseases
Kametani, F., & Hasegawa, M. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105362 · Cited by 3
Computational design of rasagiline derivatives: Searching for enhanced antioxidant capability
Reina, M., Guzmán‐López, E. G., & Galano, A. (2022) · International Journal of Quantum Chemistry · doi:10.1002/qua.27011 · Cited by 3
Yeast Chaperone Hsp70-Ssb Modulates a Variety of Protein-Based Heritable Elements
Jay-Garcia, L. M., Cornell, J. L., Howie, R. L., Faber, Q., Salas, A., Chernova, T. A., & Chernoff, Y. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108660 · Cited by 3
Advanced tumor growth modeling: A numerical study integrating phase plane analysis with finite volume method
Saleem, M., Saqib, M., Alade, T. O., Elmasry, Y., Farman, M. T., & Hasnain, S. (2024) · Ain Shams Engineering Journal · doi:10.1016/j.asej.2024.103054 · Cited by 3
NCAM2 promotes targeting of APP from the cell surface to BACE1-containing recycling endosomes
Pfundstein, G., Keable, R., Hu, S., Al-Hadi, M., Baker, M., Schachner, M., Leshchyns’ka, I., & Sytnyk, V. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102807 · Cited by 2
Exploring Therapeutic Potential: An Insight into Neurotensin Modulation of Endotoxemia Driven Hypothalamic Pituitary Adrenal Axis Dysfunction
Tiwari, A. K., & Mohanty, B. (2025) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-025-10764-5 · Cited by 2
Digital seed amplification assay for TDP‐43 aggregate quantification in CSF
Borberg, E., Swank, Z., Gilboa, T., Shearer, L. A. W., Melkonian, A. V., Rolando, J. C., Walt, D. R., & Stern, A. M. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71272 · Cited by 2
The gut-brain axis in Alzheimer’s disease: early detection, microbial metabolites, mechanisms, and therapeutic opportunities
Liu, C., Zhu, Z., Lin, H., Bush, W. S., Jenq, R. R., Cominelli, F., Pillai, J. A., Haines, J. L., Zhu, X., Xu, R., et al. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1735332 · Cited by 2
HAP40 functions as a proteostasis regulator by controlling huntingtin interactions and its release into the extracellular space
Ramos, E. S., Boeddrich, A., Haenig, C., Trepte, P., Ammar, O., Secker, C., Popp, O., Ivanov, A., Beetz, S., Roth, L., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2611301123 · Cited by 2
Toxic effects of endoplasmic reticulum stress transducer BBF2H7-derived small peptide fragments on neuronal cells
Matsuhisa, K., Cai, L., Saito, A., Sakaue, F., Kamikawa, Y. F., Fujiwara, S., Asada, R., Kudo, Y., & Imaizumi, K. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147139 · Cited by 2
Differential expression of cellular prion protein (PrPC) in mouse hepatitis virus induced neuroinflammation
Ghosh, S., Jana, R., Jana, S., Basu, R., Chatterjee, M., Ranawat, N., & Sarma, J. D. (2024) · Journal of NeuroVirology · doi:10.1007/s13365-024-01215-w · Cited by 2
Biomarkers for Neurodegenerative Diseases
Abdelmoaty, M. M., Lu, E., & Foster, E. G. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_44 · Cited by 2
Restoring neuronal excitability and spatial memory through inhibiting amyloid-β-induced hyperactive NF-κB in a rat model of Alzheimer’s disease
Soleimani, Z., Davoudi, S., Saffarzadeh, F., Behzadi, G., Mehdizadeh, M., Rahdar, M., Hosseinmardi, N., Janahmadi, M., & Eslamizade, M. J. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149703 · Cited by 2
Übergreifende Konzepte der Neurodegeneration
Becktepe, J. S., Gövert, F., & Deuschl, G. (2017) · Aktuelle Neurologie · doi:10.1055/s-0042-123500 · Cited by 2
Neuroinflammation in Age-Related Neurodegenerative Diseases
MacPherson, K. P., Rodrigues, M. E. D. S., Cintron, A. F., & Tansey, M. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00016-x · Cited by 2
Prions et transconformation protéique: une perspective historique
Hauw, J., Haı̈k, S., & Brandel, J. (2015) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30881-7 · Cited by 2
Target Tau, not Amyloid, to Prevent and Treat Alzheimer’s Disease
Esiri, M. M. (2020) · OBM Geriatrics · doi:10.21926/obm.geriatr.2001103 · Cited by 2
CD11c is not required by microglia to convey neuroprotection after prion infection
Carroll, J. A., Striebel, J. F., Baune, C., Chesebro, B. W., & Race, B. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293301 · Cited by 2
Neurodegeneration and neuroinflammation are linked, but independent of α -synuclein inclusions, in a seeding/spreading mouse model of Parkinson’s diseasePreprint
Garcia, P., Wemheuer, W. M., Huarte, O. U., Schmit, K. J., Masuch, A., Brioschi, S., Weihofen, A., Koncina, E., Coowar, D., Heurtaux, T., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.05.237750 · Cited by 2
Prionopathies and Prionlike Protein Aberrations in Neurodegenerative Diseases
Anderson, K. N., Overcast, W. B., Brosch, J. R., Graner, B. D., & Veronesi, M. C. (2021) · Neurographics · doi:10.3174/ng.2000035 · Cited by 1
Gene Therapy for Neurological Disorders
Malviya, R., Singh, A. K., Goyal, P., & Sundram, S. (2024) · Apple Academic Press eBooks · doi:10.1201/9781003494102 · Cited by 1
Impact of Lysine Acetylation Mutations on the Structure of Full-Length Tau Fibrils
Dregni, A. J., & Hong, M. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00149 · Cited by 1
Human Brain Contusions Contain Pathogenic Transmissible Species that Induce Progressive Cognitive Decline and Tau Pathology in Mice
Vegliante, G., Pischiutta, F., Restelli, E., Moro, F., Chiaravalloti, M. A., Raimondi, I., Bertani, I., Lisi, I., Sammali, E., Pascente, R., et al. (2025) · Annals of Neurology · doi:10.1002/ana.78132 · Cited by 1
Nanoscale morphological and structural analysis of round and donut oligomers formed by C-terminal domain of TDP-43
Pickett, D. N., Purvinsh, Y., Skrehot, J. T., Warren, D., & Kurouski, D. (2026) · Physical Chemistry Chemical Physics · doi:10.1039/d6cp01760f · Cited by 1
The Malignant Protein Puzzle.
Walker, L. C., & Jucker, M. (2016) · PubMed Central · Cited by 1
Self-citation
Neuroimaging Advances in Alzheimer's Disease
Schonhaut, D. R., & Rabinovici, G. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00017-2 · Cited by 1
Amyloid-β: Can One Bad Apple Really Spoil the Whole Brain? Transmission of Amyloid-β Protein Pathology From Cadaveric Pituitary Growth Hormone
Spinazzi, E. F., Upadhyayula, P. S., & McKhann, G. M. (2019) · Neurosurgery · doi:10.1093/neuros/nyz035 · Cited by 1
Association of Antineuronal Antibody Levels with Cognitive Impairment in Older Cuban Adults
Cristiá‐Lara, L., Sosa-Pérez, S., Urrutia-Amble, N., Garrudo-Guirado, A., Posada-García, A., Galán‐Garcia, L., Verde-Corvo, L., Rodríguez-Morera, M., Díaz-Casañas, M. D.-B., Bobes-León, M. A., et al. (2017) · MEDICC Review · doi:10.37757/mr2017.v19.n2-3.6 · Cited by 1
Prion receptors, prion internalization, intra- and inter-cellular transport
Celauro, L., Zattoni, M., & Legname, G. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.022 · Cited by 1
Recent advances in neurodegenerative disease research
Singh, E., & Dilawari, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00014-3 · Cited by 1
The default mode network exhibits circuit-specific selective vulnerability despite widespread amyloid burden in an animal model of Alzheimer’s disease
Brunwasser, S. J., McGregor, J. N., Bhaskaran‐Nair, K., Farris, C. A., Elmore, H., Higashikubo, B. T., Berriman-Rozen, Z. D., Ko, D., Dyer, E. L., Grady, J. M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76952-z · Cited by 1
Using patient-derived cell models to investigate the role of misfolded SOD1 in ALS
Forsgren, E. (2017) · DiVA at Umeå University (Umeå University) · Cited by 1
Modulating the aggregation of alpha-synuclein and prion protein with small molecules.
Fonseca‐Ornelas, L. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5964 · Cited by 1
XV Curso de fundamentos moleculares de la Medicina
(2018) · ANALES RANM · doi:10.32440/ar.2018.135.02.supl01 · Cited by 1
The dynamic nature of amyloid-beta protein aggregation and its association to Alzheimer’s disease
Vilaprinyó-Pascual, S. (2015) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Misfolded Alpha-Synuclein Is Implicated in Multiple System Atrophy, Suggesting the Protein Can Act Like an Infectious Prion
Talan, J. (2015) · Neurology Today · doi:10.1097/01.nt.0000472960.80306.6e
Collective Population Effects in Nonviral Systems
Domingo, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800837-9.00010-1
Neuron-to-neuron propagation of neurodegenerative proteins; relation to degradative systems
Domert, J. (2017) · Linköping University medical dissertations · doi:10.3384/diss.diva-134667
Évaluation de l'intégrité physique et fonctionnelle de la barrière hémato-encéphalique dans un modèle murin de neurodégénérescence ; impact pharmacocinétique sur un exemple de candidat médicament
Taccola, C. (2018) · theses.fr (ABES) · doi:10.70675/1b9819a9z456ez43d2z9f37z0fc46aca2754
Decreased alpha2 connectivity in EEG is correlated with the cognitive and psychiatric manifestations of Parkinson’s disease
Fuhr, P., & Gschwandtner, U. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.06.005

Authors: Walker, L. C., & Jucker, M.
Affiliations: Emory University (US)
German Center for Neurodegenerative Diseases (DE)
ORCID: Walker, Lary C.
Jucker, Mathias
Venue: Annual Review of Neuroscience
Publisher: Annual Reviews
Published: 2015-07-08
Volume: 38
Issue: 1
Pages: 87-103
ISSN: 0147-006X (ISSN-L)
1545-4126
DOI: 10.1146/annurev-neuro-071714-033828
PMC: PMC4803040
OpenAlex: W2156606243
Cited by: 361
References: 174
Citations by year: 2026: 18 · 2025: 21 · 2024: 24 · 2023: 22 · 2022: 34 · 2021: 26 · 2020: 48 · 2019: 34 · 2018: 39 · 2017: 40 · 2016: 42 · 2015: 13
FWCI: 4.33
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Annual Review of Neuroscience (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
DZNE Pub (submittedVersion)
Funders: MetLife Foundation
Bundesministerium für Bildung und Forschung (01GI0705)
National Institutes of Health (RR000165, AG025688, OD11132, P51OD011132)
National Institute on Aging (AG 025688, R21AG040589, P50AG025688, AG040589)
National Center for Research Resources (RR000165, P51RR000165)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: neurodegenerative diseases, protein misfolding, seeded aggregation, spongiform encephalopathy, prion protein, proteinopathies, transmissibility, age-related neurodegeneration, pathogenesis
MeSH terms: Animals, Humans, Prions, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neurodegenerative Diseases: Expanding the Prion Concept

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks